Comparison of Three Different Docetaxel and Cisplatin Plus Fluorouracil (Dcf) as First-Line Therapy for Advanced Gastric Cancer: a Retrospective Analysis of the Two Institution
| dc.authorwosid | Inal, Ali/J-8056-2012 | |
| dc.authorwosid | Kucukoner, Mehmet/E-1162-2013 | |
| dc.contributor.author | Inal, A. | |
| dc.contributor.author | Koca, D. | |
| dc.contributor.author | Kaplan, M. A. | |
| dc.contributor.author | Kucukoner, M. | |
| dc.contributor.author | Urakci, Z. | |
| dc.contributor.author | Dogan, E. | |
| dc.contributor.author | Isikdogan, A. | |
| dc.date.accessioned | 2025-05-10T16:57:24Z | |
| dc.date.available | 2025-05-10T16:57:24Z | |
| dc.date.issued | 2013 | |
| dc.department | T.C. Van Yüzüncü Yıl Üniversitesi | en_US |
| dc.department-temp | [Inal, A.] Dicle Univ, Diyarbakir, Turkey; [Koca, D.] Reg Training & Res Hosp, Dept Internal Dis, Div Med Oncol, Van, Turkey; [Kaplan, M. A.; Kucukoner, M.; Urakci, Z.; Isikdogan, A.] Dicle Univ, Dept Med Oncol, Diyarbakir, Turkey; [Dogan, E.] Van Yuzuncu Yil Univ, Dept Med Oncol, Van, Turkey | en_US |
| dc.description.woscitationindex | Science Citation Index Expanded - Conference Proceedings Citation Index - Science | |
| dc.identifier.endpage | S622 | en_US |
| dc.identifier.issn | 0959-8049 | |
| dc.identifier.issn | 1879-0852 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | S622 | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.14720/4038 | |
| dc.identifier.volume | 49 | en_US |
| dc.identifier.wos | WOS:000326843604043 | |
| dc.identifier.wosquality | Q1 | |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier Sci Ltd | en_US |
| dc.relation.ispartof | European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO -- SEP 27-OCT 01, 2013 -- Amsterdam, NETHERLANDS | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Comparison of Three Different Docetaxel and Cisplatin Plus Fluorouracil (Dcf) as First-Line Therapy for Advanced Gastric Cancer: a Retrospective Analysis of the Two Institution | en_US |
| dc.type | Conference Object | en_US |